Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier, Walter Prof. Dr. (1) Dahlmann, Mathias Dr. (1) Kobelt, Dennis Dr. (4) Mathas, Stephan Dr. (5) Nguyen, Tam Hoai Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (43) Smith, Janice (2) Stein, Ulrike Prof. Dr. (13) Walther, Wolfgang Prof. Dr. (9) Wollert-Wulf, Brigitte (2) (-) Daniel, Peter Prof. Dr. (2) (-) Janz, Martin Dr. (6) (-) Lusatis, Simone (1) (-) Pezzutto, Antonio Prof. Dr. (2) (-) Biologie maligner Lymphome (6) Epigenetische Regulation und Chromatinstruktur (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Immunregulation und Krebs (1) Myologie (1) Proteom Dynamik (6) RNA Biologie und Posttranscriptionale Regulation (1) (-) Translationale Onkologie solider Tumore (3) 2003 (4) 2004 (2) 2005 (3) (-) 2006 (5) 2007 (3) 2008 (2) 2009 (3) 2010 (1) 2011 (4) (-) 2012 (4) 2013 (2) 2014 (1) 2015 (2) 2016 (1) 2017 (4) 2018 (1) 2019 (1) 2020 (4) 2021 (3) 2022 (4) 2023 (6) 2024 (1) 9 Ergebnisse: Active Filter: Daniel, Peter Prof. Dr.Janz, Martin Dr.Lusatis, SimonePezzutto, Antonio Prof. Dr.Biologie maligner LymphomeTranslationale Onkologie solider Tumore20062012 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 30. April 2012 / Immunol Lett Detection of circulating tumor-associated antigen depends on the domains recognized by the monoclonal antibodies used: N-terminal trimmed EpCAM-levels are much higher than untrimmed forms O. Schmetzer G. Moldenhauer A. Nicolaou P. Schlag R. Riesenberg A. Pezzutto 01. August 2012 / Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas 01. November 2012 / Nat Immunol The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers D.P. Calado Y. Sasaki S.A. Godinho A. Pellerin K. Köchert B.P. Sleckman I.M. de Alboran M. Janz S. Rodig K. Rajewsky 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 10. Mai 2006 / BMC Cancer Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy I. Sturm B. Rau P.M. Schlag P. Wust B. Hildebrandt H. Riess S. Hauptmann B. Doerken P.T. Daniel 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. Dezember 2012 / OncoImmunology HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: gene gun is superior to jet injector in inducing CTL responses and protective immunity T. Nguyen-Hoai D. Kobelt O. Hohn M.D. Vu P.M. Schlag B. Doerken S. Norley M. Lipp W. Walther A. Pezzutto J. Westermann
30. April 2012 / Immunol Lett Detection of circulating tumor-associated antigen depends on the domains recognized by the monoclonal antibodies used: N-terminal trimmed EpCAM-levels are much higher than untrimmed forms O. Schmetzer G. Moldenhauer A. Nicolaou P. Schlag R. Riesenberg A. Pezzutto
01. August 2012 / Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas
01. November 2012 / Nat Immunol The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers D.P. Calado Y. Sasaki S.A. Godinho A. Pellerin K. Köchert B.P. Sleckman I.M. de Alboran M. Janz S. Rodig K. Rajewsky
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
10. Mai 2006 / BMC Cancer Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy I. Sturm B. Rau P.M. Schlag P. Wust B. Hildebrandt H. Riess S. Hauptmann B. Doerken P.T. Daniel
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. Dezember 2012 / OncoImmunology HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: gene gun is superior to jet injector in inducing CTL responses and protective immunity T. Nguyen-Hoai D. Kobelt O. Hohn M.D. Vu P.M. Schlag B. Doerken S. Norley M. Lipp W. Walther A. Pezzutto J. Westermann